Intradural Extramedullary Tumor

Overview

An intradural extramedullary tumor is a neoplasm that arises within the dural sac (the protective membrane surrounding the spinal cord) but outside the substance of the cord itself. Because these tumors occupy the subarachnoid space between the dura and the cord's outer surface, they displace and compress the cord and nearby nerve roots rather than infiltrating the cord tissue directly. This distinguishes them from intramedullary tumors and gives them a characteristic appearance on imaging.

The vast majority are benign and slow-growing. The two most common types are meningiomas, which arise from the cells lining the meninges, and nerve sheath tumors (schwannomas and neurofibromas), which arise from the covering of spinal nerve roots. Less common entities include myxopapillary ependymomas of the filum terminale, paragangliomas, and leptomeningeal or drop metastases from primary brain tumors or systemic cancers. Because symptoms develop slowly and may be subtle early on, there is often a prolonged period before diagnosis.

What causes it

Most cases arise sporadically without a clear cause. The distribution varies by tumor type, age, and sex. Spinal meningiomas occur predominantly in middle-aged and older women and show a strong predilection for the thoracic spine. Nerve sheath tumors are distributed more evenly between the sexes and can occur at any spinal level across a broad age range.

A subset of cases is linked to hereditary syndromes. Neurofibromatosis type 1 (NF1) predisposes to neurofibromas; neurofibromatosis type 2 (NF2) is associated with schwannomas and meningiomas; and schwannomatosis produces multiple schwannomas without the other features of neurofibromatosis. Prior spinal radiation is a recognized risk factor for the later development of a spinal meningioma. Leptomeningeal metastatic deposits within the intradural space occur in the setting of disseminated systemic cancer or tumors of the central nervous system, and these lesions carry a substantially different prognosis from the common benign tumors.

Symptoms and warning signs

Because most intradural extramedullary tumors grow slowly, the clinical course is typically insidious and gradually worsening over months to years. The most characteristic early symptom is localized or radicular spine pain (pain that may follow the distribution of a nerve root) that is notably worse at night or when lying down. This nocturnal or recumbent worsening is a well-recognized feature of intradural tumors and can help distinguish them from more common degenerative causes of back or neck pain.

As the tumor enlarges and compresses more of the spinal cord or cauda equina, patients may develop sensory disturbances such as numbness or tingling, progressive weakness in the legs or arms, gait imbalance, and bowel or bladder dysfunction. The specific pattern of deficits corresponds to the level and side of the compression: a tumor compressing one side of the cord may produce a Brown-Séquard pattern with weakness on the same side and pain and temperature loss on the opposite side; long tract signs such as brisk reflexes and spasticity may appear below the lesion.

Several presentations require urgent evaluation. Progressive motor weakness, evolving signs of spinal cord compression (myelopathy), or acute compression can cause permanent neurological injury if not addressed promptly. Tumors at the lower end of the spine affecting the conus medullaris or cauda equina may cause saddle anesthesia, urinary retention, and incontinence: features of cauda equina syndrome, which is a surgical emergency. In a patient with a known cancer history, new or worsening neurological symptoms should prompt immediate imaging to evaluate for malignant spinal involvement.

How it's diagnosed

Magnetic resonance imaging of the spine with and without gadolinium contrast is the study of choice. The hallmark appearance on MRI is a sharply marginated, contrast-enhancing mass that displaces the spinal cord to one side, widens the subarachnoid space on the same side, and produces a characteristic meniscus or capping pattern at its poles. Meningiomas often show a broad attachment to the dura and a dural tail of enhancement, while nerve sheath tumors tend to be more rounded, may extend through and widen a neural foramen in a dumbbell configuration, and can show areas of cystic change.

Computed tomography (CT) is useful for evaluating the bony spine (including foraminal widening and any calcification within the tumor) and plain radiographs may show indirect signs such as pedicle erosion or spinal curvature, though they are not sufficient for diagnosis on their own. When leptomeningeal or metastatic disease is suspected, imaging of the entire neuraxis, cerebrospinal fluid analysis (including cytology), and a search for a primary tumor outside the spine are appropriate. Careful correlation of imaging findings with the patient's symptoms and neurological examination is essential, because incidental small lesions are occasionally found and must be distinguished from those responsible for the clinical picture.

Treatment options

Management is tailored to the tumor's size, rate of growth, symptom burden, and histological type. Small, asymptomatic tumors discovered incidentally, particularly in older or medically frail patients, may be managed with a period of watchful waiting, using serial clinical examinations and interval imaging to monitor for change.

For symptomatic benign tumors and for any tumor causing progressive neurological deficit, microsurgical resection is the primary treatment and is often curative. Complete removal of a meningioma including its dural attachment, or of a schwannoma from its root of origin, frequently results in excellent neurological recovery, especially when undertaken before severe deficits are established. Intraoperative neuromonitoring is used to help protect neurological function during surgery. Stereotactic radiosurgery (a focused, non-invasive radiation technique) is an option for residual, recurrent, or surgically inaccessible lesions in selected patients.

When the intradural lesion represents metastatic disease or leptomeningeal spread from a systemic cancer, treatment shifts toward the broader oncologic plan. This may include radiotherapy to the spine, systemic chemotherapy, intrathecal chemotherapy, and corticosteroids, with surgery reserved for obtaining a tissue diagnosis or for directly decompressing a critical compressive lesion.

When surgery is considered

Surgery is indicated urgently when there is progressive myelopathy, significant or worsening motor weakness, or cauda equina compression. In these situations, prompt intervention is important because neurological recovery is more complete and durable when surgery is performed before deficits become severe or longstanding.

For benign tumors causing symptoms that are mild but persistent, or in patients in whom imaging shows a growing lesion, surgery is typically recommended before neurological function deteriorates further. The goal of surgery, complete excision when safely achievable, offers the best long-term outcome and the lowest likelihood of recurrence. For malignant or metastatic lesions compressing the spinal cord, surgery for focal decompression or tissue diagnosis may be part of a coordinated oncologic plan discussed with the patient and a multidisciplinary team.